Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Rejects Eisai’s Aquavan Injection

Jul 28 2008

• By Emily Hayes

Related Content

FDA Panel Backs MGI's Aquavan - With Proviso

May 07 2008

Eisai Strengthens Oncology Position With $3.9 Billion MGI Pharma Acquisition

Dec 10 2007

MGI Pharma Files Aquavan NDA

Sep 27 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window